• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Consumer

Capza acquires minority stake in Nutravalia

  • Ero Partsakoulaki
  • 22 June 2022
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Capza has acquired a minority stake alongside the management in Nutravalia, a French laboratory specialising in food supplements and parapharmacy products.

The GP made the transaction via its Capza 5 Flex Equity Fund, which held its final close at its hard cap of EUR 700m in May 2021, according to Unquote Data.

Nutravalia is the 14th transaction of the fund and Capza’s 35th transaction in the health and wellness sector. A debt package backing the deal was provided by Crédit du Nord, LCL, and Arkéa, according to a press release.

Nutravalia

  • DEAL:

    Expansion

  • LOCATION:

    France

  • SECTOR:

    Pharmaceuticals

  • FOUNDED:

    2015

  • TURNOVER:

    c. EUR 45 million by 2022

  • STAFF:

    50

Mergermarket had reported in March that the company was working with Sycomore on a sale, marketed off EUR 6m in EBITDA. 

The management will retain a reference shareholding, pursuing organic growth of brands in France, while considering international development and strategic acquisitions. The company aims to accelerate the development of its hair care brand, Luxéol, in France, to launch the brand internationally, starting with Spain and Italy.

“Nutravalia’s founders chose to partner with Capza as our pan-European footprint with offices in the south of Europe, Germany and Benelux would facilitate this strategic goal,” managing partner Maxence Radix told Unquote.

The company is also seeking to consolidate the position of its slimming brand 'Anaca3' in France, notably through a strong innovation pipeline and regular new product launches. The company will target organically new markets, such as the skincare segment, with new product development, according to Radix.

“We think of the investment strategy as two phases, with organic growth and new product development taking place during the first two to three years, followed by the M&A phase with opportunistic targets in France or Europe,” said Radix. “Of course, if we see an opportunity that cannot wait we’ll try to seize it.”

The company would welcome pitches from external advisors in the future as it is currently at an early stage of developing its investment strategy.

Capza foresees increasing consolidation in the pharmaceutical market in France, seeing more players coming to market following big players such as Havea, Cooper, and EA Pharma.

Nutravalia has developed an omnichannel distribution strategy, using digital technology to launch and develop its brands, before moving into pharmacies and parapharmacies. The business has experienced growth of over 54% per year on average, since 2015. It expects to achieve a turnover of about EUR 45m by 2022.

“Nutravalia’s business model with strong growth, high margin and cash conversion, as well as strong brand recognition, makes it a great fit for our Flex Equity Fund,” said Radix.

Company
Founded in 2015 by brothers Samuel and Michel Bouskila, Nutravalia designs, develops, and markets products dedicated to well-being and beauty (food supplements, cosmetics, shampoos). The group has launched two specialised brands that have rapidly entered the pharmacies and parapharmacies network: Luxéol in the hair care segment and Anaca3 in the slimming segment. Based in Mougins, near Cannes, France, Nutravalia employs around 50 people.

People
Nutravalia – Samuel Bouskila (president and founder); Michel Bouskila (managing director and founder).
Capza − Maxence Radix; Victoire Simon; Laure Tallon (partners).

Advisors
Nutravalia – Sycomore Corporate Finance François Vigne, Aurélien Singer, Quentin de Fréminville, Adrien Starck, Malo Grosso (M&A); Hogan Lovells Stéphane Huten, Paul Leroy, Florian Tranchecoste, Arnaud Biancheri, Luc Bontoux, Quentin de Donder, Ludovic Geneston, Maximilien Schmitt, Marion Guertault (legal); PwC Martin Naquet-Radiguet, Arnaud Stenger (financial DD); OC&C Stéphane Blanchard, Wassim Chraiki (strategic DD); PwC Eric Hickel, Edith Baccichetti, Bernard Borrely, Katia Gruzdova, Hélène Struve, Claire Rey, Hortense Muhorakeye, Clément Jouanolle (tax, fiscal and social DD).
Equity − Moncey Guillaume Giuliani, Marie Victoire James, Frédéric Bosc, David Malamed, Alexandre Bankowski, Jonathan Devillard, David Maréchal (legal); Oderis Thomas Claverie, Léo Paczek, Gauthier Sarre (financial DD); Indefi x Singulier David Toledano, François Beyssen (strategic DD); Moncey Guillaume Giuliani, Marie Victoire James, Frédéric Bosc, Alexandre Bankowski, Bonnie Brenier, Mathilde Cotillon, Anastasia Fleury (tax, fiscal and social DD).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Consumer
  • France
  • Expansion
  • France
  • Capzanine

More on Consumer

Reima Linnanvirta of Trind VC
Trind VC plans up to five early-stage investments in next six months

VC has deployed around 10% of its second, EUR 55m fund and plans to invest in up to 40 startups

  • Venture
  • 31 August 2023
Lender taking the keys from a sponsor
Ares Management handed keys to two-thirds of UK sponsor’s portfolio

Lender provided GBP 500m for three of the GP's deals between 2016 and 2019, Debtwire reported

  • Financing
  • 30 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023
Big Ben and British flag London UK
CMA scrutiny of high-leverage PE divestment purchases expected to increase

PE could stand to lose its historic advantage with heightened regulatory baggage

  • Regulation
  • 21 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013